Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

liposomal tretinoin

An intravenous formulation of tretinoin (vitamin A acid or all-trans retinoic acid) encased in liposomes. Tretinoin is a naturally occurring retinoic acid agent that binds to and activates retinoic acid receptors (RAR), effecting changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of carcinogenesis. This agent also inhibits telomerase, leading to telomere shortening and eventual apoptosis of certain tumor cell types. Liposome encapsulation extends the half-life of intravenously administered tretinoin.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:All-trans-retinoic acid liposomal
tretinoin liposomal
tretinoin liposome
tretinoinLF
US brand name:Atragen
Abbreviation:L-ATRA
Code name:AR-623
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search